| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 537.29B | 550.76B | 566.44B | 535.64B | 525.09B | 519.94B |
| Gross Profit | 114.91B | 138.95B | 159.63B | 158.64B | 160.30B | 158.29B |
| EBITDA | 18.41B | 38.26B | 52.06B | 49.26B | 51.59B | 34.07B |
| Net Income | -26.30B | -20.13B | 37.08B | 46.85B | 24.88B | 10.11B |
Balance Sheet | ||||||
| Total Assets | 1.44T | 1.44T | 1.45T | 1.38T | 1.34T | 1.34T |
| Cash, Cash Equivalents and Short-Term Investments | 196.08B | 198.29B | 197.54B | 209.71B | 196.15B | 193.66B |
| Total Debt | 376.76B | 352.52B | 323.11B | 265.26B | 270.91B | 277.32B |
| Total Liabilities | 622.37B | 610.27B | 579.20B | 533.87B | 527.20B | 551.61B |
| Stockholders Equity | 806.72B | 818.17B | 857.92B | 837.68B | 798.07B | 774.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.80B | -49.91B | 12.16B | 15.92B | 4.80B |
| Operating Cash Flow | 0.00 | 58.45B | 47.80B | 61.78B | 53.86B | 45.84B |
| Investing Cash Flow | 0.00 | -37.49B | -106.53B | -32.77B | -46.79B | -26.61B |
| Financing Cash Flow | 0.00 | 2.46B | 25.24B | -5.27B | -24.89B | 20.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥1.05T | 36.08 | 7.76% | 1.67% | 3.12% | 21.97% | |
74 Outperform | ¥109.37B | 14.19 | ― | 1.71% | 5.83% | 28.78% | |
70 Outperform | ¥916.66B | 21.98 | 5.45% | 1.30% | 5.29% | 30.89% | |
69 Neutral | ¥754.29B | 11.82 | 6.38% | 1.03% | 8.01% | 103.83% | |
64 Neutral | ¥327.93B | 6.57 | 7.48% | 1.79% | 6.94% | 57.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | ¥571.08B | 25.92 | -2.45% | 1.40% | -6.99% | -148.41% |